1 Fluorouracil Injection Market Overview
1.1 Product Overview and Scope of Fluorouracil Injection
1.2 Fluorouracil Injection Segment by Type
1.2.1 Global Fluorouracil Injection Market Value Comparison by Type (2023-2029)
1.2.2 0.25g/10ml
1.2.3 0.5g/10ml
1.3 Fluorouracil Injection Segment by Application
1.3.1 Global Fluorouracil Injection Market Value by Application: (2023-2029)
1.3.2 Digestive Tract Tumor
1.3.3 Chorionic Epithelial Carcinoma
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Global Fluorouracil Injection Market Size Estimates and Forecasts
1.4.1 Global Fluorouracil Injection Revenue 2018-2029
1.4.2 Global Fluorouracil Injection Sales 2018-2029
1.4.3 Global Fluorouracil Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Fluorouracil Injection Market Competition by Manufacturers
2.1 Global Fluorouracil Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Fluorouracil Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Fluorouracil Injection Average Price by Manufacturers (2018-2023)
2.4 Global Fluorouracil Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Fluorouracil Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fluorouracil Injection, Product Type & Application
2.7 Fluorouracil Injection Market Competitive Situation and Trends
2.7.1 Fluorouracil Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fluorouracil Injection Players Market Share by Revenue
2.7.3 Global Fluorouracil Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fluorouracil Injection Retrospective Market Scenario by Region
3.1 Global Fluorouracil Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Fluorouracil Injection Global Fluorouracil Injection Sales by Region: 2018-2029
3.2.1 Global Fluorouracil Injection Sales by Region: 2018-2023
3.2.2 Global Fluorouracil Injection Sales by Region: 2024-2029
3.3 Global Fluorouracil Injection Global Fluorouracil Injection Revenue by Region: 2018-2029
3.3.1 Global Fluorouracil Injection Revenue by Region: 2018-2023
3.3.2 Global Fluorouracil Injection Revenue by Region: 2024-2029
3.4 North America Fluorouracil Injection Market Facts & Figures by Country
3.4.1 North America Fluorouracil Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Fluorouracil Injection Sales by Country (2018-2029)
3.4.3 North America Fluorouracil Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fluorouracil Injection Market Facts & Figures by Country
3.5.1 Europe Fluorouracil Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Fluorouracil Injection Sales by Country (2018-2029)
3.5.3 Europe Fluorouracil Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fluorouracil Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Fluorouracil Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Fluorouracil Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Fluorouracil Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fluorouracil Injection Market Facts & Figures by Country
3.7.1 Latin America Fluorouracil Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Fluorouracil Injection Sales by Country (2018-2029)
3.7.3 Latin America Fluorouracil Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fluorouracil Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Fluorouracil Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Fluorouracil Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Fluorouracil Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Fluorouracil Injection Sales by Type (2018-2029)
4.1.1 Global Fluorouracil Injection Sales by Type (2018-2023)
4.1.2 Global Fluorouracil Injection Sales by Type (2024-2029)
4.1.3 Global Fluorouracil Injection Sales Market Share by Type (2018-2029)
4.2 Global Fluorouracil Injection Revenue by Type (2018-2029)
4.2.1 Global Fluorouracil Injection Revenue by Type (2018-2023)
4.2.2 Global Fluorouracil Injection Revenue by Type (2024-2029)
4.2.3 Global Fluorouracil Injection Revenue Market Share by Type (2018-2029)
4.3 Global Fluorouracil Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Fluorouracil Injection Sales by Application (2018-2029)
5.1.1 Global Fluorouracil Injection Sales by Application (2018-2023)
5.1.2 Global Fluorouracil Injection Sales by Application (2024-2029)
5.1.3 Global Fluorouracil Injection Sales Market Share by Application (2018-2029)
5.2 Global Fluorouracil Injection Revenue by Application (2018-2029)
5.2.1 Global Fluorouracil Injection Revenue by Application (2018-2023)
5.2.2 Global Fluorouracil Injection Revenue by Application (2024-2029)
5.2.3 Global Fluorouracil Injection Revenue Market Share by Application (2018-2029)
5.3 Global Fluorouracil Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Accord Healthcare Fluorouracil Injection Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Ebewe Pharma
6.2.1 Ebewe Pharma Corporation Information
6.2.2 Ebewe Pharma Description and Business Overview
6.2.3 Ebewe Pharma Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ebewe Pharma Fluorouracil Injection Product Portfolio
6.2.5 Ebewe Pharma Recent Developments/Updates
6.3 Eugia Pharma Speclts
6.3.1 Eugia Pharma Speclts Corporation Information
6.3.2 Eugia Pharma Speclts Description and Business Overview
6.3.3 Eugia Pharma Speclts Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eugia Pharma Speclts Fluorouracil Injection Product Portfolio
6.3.5 Eugia Pharma Speclts Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Fluorouracil Injection Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Gland Pharma
6.5.1 Gland Pharma Corporation Information
6.5.2 Gland Pharma Description and Business Overview
6.5.3 Gland Pharma Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gland Pharma Fluorouracil Injection Product Portfolio
6.5.5 Gland Pharma Recent Developments/Updates
6.6 Novast Labs
6.6.1 Novast Labs Corporation Information
6.6.2 Novast Labs Description and Business Overview
6.6.3 Novast Labs Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novast Labs Fluorouracil Injection Product Portfolio
6.6.5 Novast Labs Recent Developments/Updates
6.7 Sagent Pharms
6.6.1 Sagent Pharms Corporation Information
6.6.2 Sagent Pharms Description and Business Overview
6.6.3 Sagent Pharms Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sagent Pharms Fluorouracil Injection Product Portfolio
6.7.5 Sagent Pharms Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sandoz Fluorouracil Injection Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Teva Pharms USA
6.9.1 Teva Pharms USA Corporation Information
6.9.2 Teva Pharms USA Description and Business Overview
6.9.3 Teva Pharms USA Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Teva Pharms USA Fluorouracil Injection Product Portfolio
6.9.5 Teva Pharms USA Recent Developments/Updates
6.10 Cheng Yi Pharmaceutical
6.10.1 Cheng Yi Pharmaceutical Corporation Information
6.10.2 Cheng Yi Pharmaceutical Description and Business Overview
6.10.3 Cheng Yi Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cheng Yi Pharmaceutical Fluorouracil Injection Product Portfolio
6.10.5 Cheng Yi Pharmaceutical Recent Developments/Updates
6.11 Dahongying Pharmaceutical
6.11.1 Dahongying Pharmaceutical Corporation Information
6.11.2 Dahongying Pharmaceutical Fluorouracil Injection Description and Business Overview
6.11.3 Dahongying Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Dahongying Pharmaceutical Fluorouracil Injection Product Portfolio
6.11.5 Dahongying Pharmaceutical Recent Developments/Updates
6.12 Fuhe Pharmaceuticals
6.12.1 Fuhe Pharmaceuticals Corporation Information
6.12.2 Fuhe Pharmaceuticals Fluorouracil Injection Description and Business Overview
6.12.3 Fuhe Pharmaceuticals Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Fuhe Pharmaceuticals Fluorouracil Injection Product Portfolio
6.12.5 Fuhe Pharmaceuticals Recent Developments/Updates
6.13 Jin Yao pharmaceutical
6.13.1 Jin Yao pharmaceutical Corporation Information
6.13.2 Jin Yao pharmaceutical Fluorouracil Injection Description and Business Overview
6.13.3 Jin Yao pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jin Yao pharmaceutical Fluorouracil Injection Product Portfolio
6.13.5 Jin Yao pharmaceutical Recent Developments/Updates
6.14 Jiuzhou Pharmaceutiacal
6.14.1 Jiuzhou Pharmaceutiacal Corporation Information
6.14.2 Jiuzhou Pharmaceutiacal Fluorouracil Injection Description and Business Overview
6.14.3 Jiuzhou Pharmaceutiacal Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Jiuzhou Pharmaceutiacal Fluorouracil Injection Product Portfolio
6.14.5 Jiuzhou Pharmaceutiacal Recent Developments/Updates
6.15 Lingnan Pharmaceutical
6.15.1 Lingnan Pharmaceutical Corporation Information
6.15.2 Lingnan Pharmaceutical Fluorouracil Injection Description and Business Overview
6.15.3 Lingnan Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Lingnan Pharmaceutical Fluorouracil Injection Product Portfolio
6.15.5 Lingnan Pharmaceutical Recent Developments/Updates
6.16 Taiyuan Pharmaceutical
6.16.1 Taiyuan Pharmaceutical Corporation Information
6.16.2 Taiyuan Pharmaceutical Fluorouracil Injection Description and Business Overview
6.16.3 Taiyuan Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Taiyuan Pharmaceutical Fluorouracil Injection Product Portfolio
6.16.5 Taiyuan Pharmaceutical Recent Developments/Updates
6.17 Wuzhong Pharmaceutical
6.17.1 Wuzhong Pharmaceutical Corporation Information
6.17.2 Wuzhong Pharmaceutical Fluorouracil Injection Description and Business Overview
6.17.3 Wuzhong Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Wuzhong Pharmaceutical Fluorouracil Injection Product Portfolio
6.17.5 Wuzhong Pharmaceutical Recent Developments/Updates
6.18 Southwest Pharmaceutical
6.18.1 Southwest Pharmaceutical Corporation Information
6.18.2 Southwest Pharmaceutical Fluorouracil Injection Description and Business Overview
6.18.3 Southwest Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Southwest Pharmaceutical Fluorouracil Injection Product Portfolio
6.18.5 Southwest Pharmaceutical Recent Developments/Updates
6.19 Xudong Haipu
6.19.1 Xudong Haipu Corporation Information
6.19.2 Xudong Haipu Fluorouracil Injection Description and Business Overview
6.19.3 Xudong Haipu Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Xudong Haipu Fluorouracil Injection Product Portfolio
6.19.5 Xudong Haipu Recent Developments/Updates
6.20 Yabao Pharmaceutical
6.20.1 Yabao Pharmaceutical Corporation Information
6.20.2 Yabao Pharmaceutical Fluorouracil Injection Description and Business Overview
6.20.3 Yabao Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Yabao Pharmaceutical Fluorouracil Injection Product Portfolio
6.20.5 Yabao Pharmaceutical Recent Developments/Updates
6.21 Yaoda Leiyunshang
6.21.1 Yaoda Leiyunshang Corporation Information
6.21.2 Yaoda Leiyunshang Fluorouracil Injection Description and Business Overview
6.21.3 Yaoda Leiyunshang Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Yaoda Leiyunshang Fluorouracil Injection Product Portfolio
6.21.5 Yaoda Leiyunshang Recent Developments/Updates
6.22 Youcare Pharmaceutical
6.22.1 Youcare Pharmaceutical Corporation Information
6.22.2 Youcare Pharmaceutical Fluorouracil Injection Description and Business Overview
6.22.3 Youcare Pharmaceutical Fluorouracil Injection Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Youcare Pharmaceutical Fluorouracil Injection Product Portfolio
6.22.5 Youcare Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fluorouracil Injection Industry Chain Analysis
7.2 Fluorouracil Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fluorouracil Injection Production Mode & Process
7.4 Fluorouracil Injection Sales and Marketing
7.4.1 Fluorouracil Injection Sales Channels
7.4.2 Fluorouracil Injection Distributors
7.5 Fluorouracil Injection Customers
8 Fluorouracil Injection Market Dynamics
8.1 Fluorouracil Injection Industry Trends
8.2 Fluorouracil Injection Market Drivers
8.3 Fluorouracil Injection Market Challenges
8.4 Fluorouracil Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 フルオロウラシル注射液は、がん治療に広く用いられる抗代謝薬の一種であり、特に固形腫瘍の治療において重要な役割を果たします。この薬剤は、細胞分裂のプロセスに干渉することによって、癌細胞の増殖を抑制する働きがあります。フルオロウラシルは、1957年に初めて腫瘍治療に用いられるようになり、その後の数十年間にわたり、様々な癌治療において不可欠な薬剤となっています。 フルオロウラシルは、ピリミジン系の化合物であり、体内で代謝されることで、細胞のDNAおよびRNAの合成を阻害します。具体的には、酵素チミジル酸合成酵素に結合してその活性を阻害し、これによりDNAの合成過程に必要な成分が欠乏状態になります。この結果、癌細胞の分裂が抑制され、増殖が抑えられるわけです。 フルオロウラシルの射出形態は、注射液として提供され、主に静脈内投与で使用されます。通常、点滴投与やボーラス（単回）投与が行われます。フルオロウラシルは、単剤療法として、あるいは他の抗癌薬との併用療法として用いられることが多く、特に大腸癌、胃癌、乳癌、膵癌などの治療において効果を発揮します。 この薬剤の特徴として、副作用が挙げられます。フルオロウラシルは、正常な細胞にも影響を与えるため、白血球や血小板の減少、消化器系の障害、口内炎、脱毛などさまざまな副作用が見られることがあります。特に白血球数が減少すると感染症にかかりやすくなるため、患者の健康管理には注意が必要です。 また、フルオロウラシルの投与に際しては、患者の体調や腫瘍の特性に応じた適切な用量の設定が求められます。用量は患者の体 surface area（体表面積）に基づいて計算されることが一般的ですが、腎機能や肝機能の状態に応じた調整も必要とされることがあります。 近年では、フルオロウラシルの薬剤治療における効果を向上させるため、薬剤の投与方法や併用薬の研究が進められています。例えば、フルオロウラシルとロイコボリンを併用することで、フルオロウラシルの効果を高める治療法や、他の新しい抗癌剤との併用による治療効果の増強が試みられています。これにより、腫瘍の抗薬剤性を克服するための新たな治療法が模索されています。 関連する技術としては、フルオロウラシルの血中濃度モニタリングや、腫瘍マーカーの測定技術、さらに、遺伝子解析を用いた個別化医療の進展もあります。これにより、患者それぞれの病態に応じたより適切な治療アプローチが可能となりつつあります。 フルオロウラシルは、長い歴史を持つがん治療薬ではありますが、その効果と副作用のバランスを考慮しながら、より良い治療法を探索することが今後の課題となります。がん患者の生活の質を向上させるためには、フルオロウラシルだけでなく、様々な治療法を組み合わせたマルチモーダルアプローチが重要であると考えられます。フルオロウラシル注射液は、その中心的な役割を担う薬剤として、今後もがん治療において重要視されることでしょう。 |
